Evaluating SH-SY5Y cells as a dopaminergic neuronal model: morphological, transcriptomic, and proteomic insights
Open Access
- 28 October 2025
- journal article
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF BIOLOGY
- Vol. 49 (6) , 700-711
Abstract
Background/aim: The SH-SY5Y neuroblastoma cell line is a popular in vitro model for neurodegenerative disease research, especially Parkinson’s disease (PD) research, but its use is complicated by limitations like the persistence of neuroblastoma-like features, unstable differentiation, mitochondrial dysfunction, and cellular stress. To address these limitations, this study tested a blended, nine-day differentiation protocol that sequentially applied all-trans retinoic acid (RA), brain-derived neurotrophic factor (BDNF), and dibutyryl cyclic adenosine monophosphate (dbcAMP). By evaluating key neuronal, dopaminergic, and PD-related markers, the research aims to determine if these differentiated SH-SY5Y cells are a suitable model for studying PD. Materials and methods: A blended differentiation protocol using RA, BDNF, and dbcAMP was applied to SH-SY5Y cells. Morphological changes were evaluated by immunofluorescence microscopy. Furthermore, mostly dopaminergic neuronal markers associated with PD were used for characterization purposes. Nanoliquid chromatography coupled with tandem mass spectrometry proteome analysis was performed to identify changes in protein expression related to differentiation. Results: Differentiation led to neuron-like morphology with extended neurites. Gene expression analyses revealed upregulation of several neuronal markers, such as Nestin and MAP2, indicating progression from progenitor to neuron-like states. Furthermore, some dopaminergic markers, such as TH and Nurr1, showed elevated expression with asynchronous expression patterns, suggesting heterogeneity in the differentiation process. Proteomic analysis indicated significant changes in cell differentiation and neurogenesis. Transient expression of key neuronal markers was observed. The cells required continuous external stimuli. Conclusion: While SH-SY5Y cells exhibited dopaminergic characteristics following the blended differentiation protocol, the transient expression of key neuronal markers and the need for continuous external stimuli raised concerns about the stability and functional maturity of these differentiated cells as an in vitro PD model. These findings suggest that SH-SY5Y cells might not fully capture the properties of mature neurons.Keywords
This publication has 49 references indexed in Scilit:
- Microtubule-Associated Protein 2, a Marker of Neuronal Differentiation, Induces Mitotic Defects, Inhibits Growth of Melanoma Cells, and Predicts Metastatic Potential of Cutaneous MelanomaThe American Journal of Pathology, 2005
- Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like CellsJournal of Neurochemistry, 2000
- Discoidin domain receptor 1 functions in axon extension of cerebellar granule neuronsGenes & Development, 2000
- Extracellular‐Regulated Kinases and Phosphatidylinositol 3‐Kinase Are Involved in Brain‐Derived Neurotrophic Factor‐Mediated Survival and neuritogenesis of the Neuroblastoma Cell Line SH‐SY5YJournal of Neurochemistry, 1999
- Retinoids and the control of growth/death decisions in human neuroblastoma cell linesJournal of Neuro-Oncology, 1997
- Nerve Growth Factor‐Induced Differentiation in Neuroblastoma Cells Expressing TrkA but Lacking p75NGFRJournal of Neurochemistry, 1994
- Induction of TrkB by retinoic acid mediates biologic responsiveness to BDNF and differentiation of human neuroblastoma cellsNeuron, 1993
- PRESENCE AND REGULATION OF TYROSINASE ACTIVITY IN HUMAN NEURO-BLASTOMA CELL VARIANTS INVITRO1985
- Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiationCell Differentiation, 1984
- TYROSINE HYDROXYLASE - INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS1964